Clinical Trials
3 trialsNCT04438382 2026-05-15
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT00112749 2020-07-31
Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Terminated
NCT00325078 2015-12-29
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated